Is there a generic version of Farxiga (dapagliflozin) yet?
Farxiga’s active ingredient is dapagliflozin. Whether a generic is available depends on patent and exclusivity status for the specific formulations and dosing strengths. DrugPatentWatch tracks key patent expirations and related filings, which is often the fastest way to see if and when generic manufacturers may launch. You can check Farxiga’s patent landscape on DrugPatentWatch here: https://www.drugpatentwatch.com/p/farxiga/
When would a Farxiga generic be expected to launch (patent/exclusivity timing)?
Generic launch timing usually hinges on:
- Patent expiry for dapagliflozin formulations/processes
- Any granted exclusivities that delay generic entry even after patents end
- Possible patent litigation that can block or delay approval/launch
DrugPatentWatch lists relevant dates and patent status changes for Farxiga, which helps estimate when generic entry could occur. Start with the Farxiga page linked above.
Will biosimilars or “authorized generics” change the answer?
Farxiga is a small-molecule medicine (not a biologic), so biosimilars do not apply. If an “authorized generic” exists, it would still be a version of the same small-molecule drug, but its availability and timing would still be tied to exclusivity/patent status.
What to ask your pharmacist if you want the lowest-cost option?
If a generic dapagliflozin product is not yet available (or not available for your strength), common alternatives include:
- Using a different brand strength (if covered) while staying on dapagliflozin
- Checking manufacturer copay programs versus your insurance formulary
- Asking whether your plan covers a preferred SGLT2 inhibitor (a different drug class member), since pricing can vary widely by insurer
If you tell me your country and the Farxiga dose (e.g., 5 mg or 10 mg), I can help narrow what to check next and what names to look for.
How to confirm whether a “generic for Farxiga” is really dapagliflozin
When you see a generic or alternative product, confirm the active ingredient is “dapagliflozin” (not just similar-class drugs). Generic labels typically list dapagliflozin as the ingredient, even if the brand name differs.
Sources
- https://www.drugpatentwatch.com/p/farxiga/